Purged Circulating Tumor Cells (CTCs) From Met Breast Cancer (Phase II, <60 yrs)
http://clinicaltrials.gov/ct2/show/s...ow_desc=Y#desc
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer http://clinicaltrials.gov/ct2/html/i...e/triangle.gif Purpose Primary Objectives:This study is currently recruiting participants. Verified by M.D. Anderson Cancer Center, May 2009 First Received: January 29, 2007 Last Updated: May 27, 2009 History of Changes Sponsored by: M.D. Anderson Cancer Center Information provided by: M.D. Anderson Cancer Center ClinicalTrials.gov Identifier: NCT00429182
Condition Intervention Phase Breast Cancer Drug: Carboplatin Drug: Cyclophosphamide Drug: Thiotepa Procedure: Stem Cell Transplant Phase II Study Type: Interventional Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study Official Title: Phase II Study of Purging of Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer Patients |
All times are GMT -7. The time now is 07:31 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021